Abstract
McCune-Albright syndrome is characterized by café-au-lait spot, multiple endocrine hyperfunction, and polyostotic fibrous dysplasia. A somatic point mutation of Gsα protein leads to an increase in the Gsα-associated hormone activity in McCune-Albright syndrome. Because cyclic adenosine 3′,5′-monophosphate stimulates the dopamine beta hydroxylase gene, an activating mutation of the Gsα protein may cause the hyperproduction of norepinephrine via dopamine. We report on a 9-year-old girl with McCune-Albright syndrome complicated by severe arterial hypertension. The urinary excretion of norepinephrine was 5- to 10-fold higher than in age-matched controls. Meta-iodobenzylguanidine scintigraphy and positron emission tomography/computed tomography (PET/CT) revealed no hot spots. These findings suggest that severe hypertension might be due to an activating mutation of Gsα protein in sympathetic ganglia. Because of the reported association of GNAS1 gene polymorphism with hypertension, our patient provides further evidence for a role of Gsα protein in hypertension.
Abbreviations
- MAS:
-
McCune-Albright syndrome
- GTPase:
-
Guanosine triphosphatase
- cAMP:
-
Cyclic adenosine 3′,5′-monophosphate
- LH:
-
Luteinizing hormone
- TSH:
-
Thyroid-stimulating hormone
- ACTH:
-
Adrenocorticotropin
- GHRH:
-
Growth hormone-releasing hormone
- FGF:
-
Fibroblast growth factor
- GH:
-
Growth hormone
- CT:
-
Computed tomography
- MIBG:
-
Meta-iodobenzylguanidine
- PET/CT:
-
Positron emission tomography/computed tomography
References
Abe M, Nakura J, Yamamoto M et al (2002) Association of GNAS1 gene variant with hypertension depending on smoking status. Hypertension 40:261–265
Akintoye SO, Chebli C, Booher S et al (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:5104–5112
Bernstein D (2004) Systemic hypertension. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 17th edn, Saunders, Philadelphia, pp 1592–1598
Bonnet N, Benhamou CL, Brunet-Imbault B et al (2005) Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone 37:622–633
Colao A, Ferone D, Marzullo P et al (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152
De Wachter E, Vanbesien J, De Schutter I et al (2003) Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide. Eur J Pediatr 162:488–489
Elefteriou F, Ahn JD, Takeda S et al (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514–520
Fragoso MC, Domenice S, Latronico AC et al (2003) Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 88:2147–2151
Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273:669–672
Hein L (2006) Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326:541–551
Jonsson KB, Zahradnik R, Larsson T et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663
Kim KS, Ishiguro H, Tinti C et al (1994) The cAMP-dependent protein kinase regulates transcription of the dopamine beta-hydroxylase gene. J Neurosci 14:7200–7207
Landis CA, Masters SB, Spada A et al (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692–696
Marini JC (2003) Do bisphosphonates make children’s bones better or brittle? N Engl J Med 349:423–426
Nakanishi N, Onozawa S, Matsumoto R et al (1995) Cyclic AMP-dependent modulation of vesicular monoamine transport in pheochromocytoma cells. J Neurochem 64:600–607
Sadler TW (1995) Autonomic nervous system. In: Sadler TW (ed). Langman’s medical embryology, 7th edn. Williams & Wilkins, Baltimore, pp 366–369
Schwindinger WF, Francomano CA, Levine MA (1992) Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152–5156
Spark RF, Dickstein G, Pallotta J (1979) Complete remission of acromegaly with medical treatment. JAMA 241:573–575
Spiegel AM, Shenker A, Weinstein LS (1992) Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr Rev 13:536–565
Wada M, Azuma H, Bando H et al (1996) A case report of an elderly patient with acromegaly. Endocr J 43:715–718
Weinstein LS, Shenker A, Gejman PV et al (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688–1695
Yamamoto T, Imanishi Y, Kinoshita E et al (2005) The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. J Bone Miner Metab 23:231–237
Yamamoto T, Ozono K, Kasayama S et al (1996) Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 98:30–35
Acknowledgment
We thank Dr. Tsuyoshi Chihara for performing the autopsy, Dr. Tomohiko Sakai for the emergency room care, and Dr. Hisao Yoshida for treating the patient when she had viral pneumonia.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yasuhisa Ohata wrote the first draft of the manuscript and there have not been any honorarium, grant, or other form of payment to any of the authors in relation to this manuscript.
Rights and permissions
About this article
Cite this article
Ohata, Y., Yamamoto, T., Mori, I. et al. Severe arterial hypertension: a possible complication of McCune-Albright syndrome. Eur J Pediatr 168, 871–876 (2009). https://doi.org/10.1007/s00431-008-0848-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-008-0848-1